Staten Island, New York — Staten Island, New York

Staten Island, New York is a clinical research site located in Staten Island, New York, United States 10314-1607.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Staten Island, New York has participated in 4 clinical trials.

Therapeutic areas: Schizophrenia, Healthy Participants, Alzheimer's Disease Dementia.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Staten Island, New York?

Staten Island, New York has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Staten Island, New York conducted?

Staten Island, New York has 4 clinical trials on record. Their work covers Schizophrenia, Healthy Participants, Alzheimer's Disease Dementia.

Is Staten Island, New York accredited by Crixeo Health?

Staten Island, New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Staten Island, New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.